OGN Long Call Strategy
OGN (Organon & Co.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions.
OGN (Organon & Co.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $3.50B, a trailing P/E of 14.12, a beta of 1.55 versus the broader market, a 52-week range of 5.69-13.44, average daily share volume of 9.1M, a public-listing history dating back to 2021, approximately 10K full-time employees. These structural characteristics shape how OGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.55 indicates OGN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. OGN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on OGN?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current OGN snapshot
As of May 15, 2026, spot at $13.39, ATM IV 3.80%, IV rank 0.57%, expected move 1.09%. The long call on OGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this long call structure on OGN specifically: OGN IV at 3.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a OGN long call, with a market-implied 1-standard-deviation move of approximately 1.09% (roughly $0.15 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on OGN should anchor to the underlying notional of $13.39 per share and to the trader's directional view on OGN stock.
OGN long call setup
The OGN long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OGN near $13.39, the first option leg uses a $13.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OGN chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $13.00 | $0.65 |
OGN long call risk and reward
- Net Premium / Debit
- -$65.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$65.00
- Breakeven(s)
- $13.65
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
OGN long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on OGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$65.00 |
| $2.97 | -77.8% | -$65.00 |
| $5.93 | -55.7% | -$65.00 |
| $8.89 | -33.6% | -$65.00 |
| $11.85 | -11.5% | -$65.00 |
| $14.81 | +10.6% | +$115.75 |
| $17.77 | +32.7% | +$411.70 |
| $20.73 | +54.8% | +$707.65 |
| $23.69 | +76.9% | +$1,003.60 |
| $26.65 | +99.0% | +$1,299.55 |
When traders use long call on OGN
Long calls on OGN express a bullish thesis with defined risk; traders use them ahead of OGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
OGN thesis for this long call
The market-implied 1-standard-deviation range for OGN extends from approximately $13.24 on the downside to $13.54 on the upside. A OGN long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current OGN IV rank near 0.57% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OGN at 3.80%. As a Healthcare name, OGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OGN-specific events.
OGN long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OGN alongside the broader basket even when OGN-specific fundamentals are unchanged. Long-premium structures like a long call on OGN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current OGN chain quotes before placing a trade.
Frequently asked questions
- What is a long call on OGN?
- A long call on OGN is the long call strategy applied to OGN (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With OGN stock trading near $13.39, the strikes shown on this page are snapped to the nearest listed OGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are OGN long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the OGN long call priced from the end-of-day chain at a 30-day expiry (ATM IV 3.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$65.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OGN long call?
- The breakeven for the OGN long call priced on this page is roughly $13.65 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OGN market-implied 1-standard-deviation expected move is approximately 1.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on OGN?
- Long calls on OGN express a bullish thesis with defined risk; traders use them ahead of OGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current OGN implied volatility affect this long call?
- OGN ATM IV is at 3.80% with IV rank near 0.57%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.